Sei Investments CO Crispr Therapeutics Ag Transaction History

Sei Investments CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $109,571 - $142,426	-2,414 Reduced 4.17%	55,455 $2.52 Million
Q2 2023 Aug 11, 2023	SELL	$43.47 - $67.77 $294,031 - $458,396	-6,764 Reduced 10.47%	57,869 $3.25 Million
Q1 2023 May 12, 2023	BUY	$41.0 - $56.12 $2.65 Million - $3.63 Million	64,633 New	64,633 $2.92 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $152,383 - $208,947	2,494 Added 4.83%	54,179 $3.54 Million
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $2.23 Million - $3.82 Million	51,685 New	51,685 $3.14 Million
Q1 2022 May 13, 2022	SELL	$53.19 - $79.24 $172,335 - $256,737	-3,240 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $40,371 - $64,103	-576 Reduced 15.09%	3,240 $247,000
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $70,748 - $100,562	642 Added 20.23%	3,816 $427,000
Q2 2021 Aug 06, 2021	BUY	$100.84 - $161.89 $82,386 - $132,264	817 Added 34.66%	3,174 $514,000
Q1 2021 May 12, 2021	BUY	$110.72 - $210.04 $28,344 - $53,770	256 Added 12.18%	2,357 $287,000
Q4 2020 Feb 08, 2021	BUY	$79.67 - $173.23 $167,386 - $363,956	2,101 New	2,101 $322,000
Q3 2018 Nov 08, 2018	SELL	$44.35 - $65.71 $35,480 - $52,567	-800 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$23.52 - $58.17 $18,816 - $46,536	800 New	800 $37,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.